Insulin Pump Insurance Denied: How to Appeal

Continuous subcutaneous insulin infusion (CSII) therapy — commonly called an insulin pump — is a well-established, effective treatment for Type 1 diabetes and certain cases of Type 2 diabetes. Despite strong clinical evidence, insurers frequently deny insulin pump coverage, citing failure to meet Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization criteria. Here is how to document your case and appeal successfully.

Why Insulin Pumps Get Denied

Most insurance denials for insulin pumps fall into one of these categories:

• Prior authorization not submitted or incomplete: The physician's office may not have provided all required documentation
• Failure to meet criteria: The insurer claims the patient does not meet their specific eligibility criteria
• Not medically necessary: The insurer argues that multiple daily injection (MDI) therapy is adequate
• Durable Medical Equipment (DME) benefit exhausted or not covered: The pump falls under the DME benefit, which may have separate deductibles or be excluded from some plans

Standard Prior Authorization Criteria

Most insurers use criteria similar to the American Diabetes Association (ADA) and the American Association of Clinical Endocrinology (AACE) standards. Typical requirements include one or more of:

Type 1 diabetes with demonstrated need:

• Inadequate glycemic control on MDI therapy (elevated A1C, typically above 8% despite compliance)
• Recurrent hypoglycemia (frequent low blood sugar episodes) on MDI, particularly nocturnal hypoglycemia or hypoglycemia unawareness
• Significant glycemic variability on MDI
• Patient has been educated in intensive diabetes management and carbohydrate counting
• Patient demonstrates the ability and motivation to manage a pump

Type 2 diabetes with demonstrated need (higher bar):

• Insulin-requiring Type 2 with documentation of failure of multiple insulin regimens
• Clinical indication from endocrinologist

Documentation your physician should provide:

• Most recent A1C values (with dates)
• Records of hypoglycemic episodes — glucose log data, emergency visits
• Documentation of current insulin regimen (doses, timing, compliance)
• Statement that the patient has been trained in intensive diabetes management
• A letter from an endocrinologist supporting pump therapy

Medicare DMEPOS Coverage for Insulin Pumps

Under Medicare, insulin pumps are covered as Durable Medical Equipment (DME) under Part B. Medicare's criteria include:

• Diagnosis of Type 1 or insulin-requiring Type 2 diabetes
• Inadequate glycemic control on MDI (A1C above 7% despite optimal MDI therapy)
• Patient is motivated and capable of managing a pump
• The prescribing physician must be actively involved in the treatment plan

For Medicare, the pump itself is covered at 80% under Part B after the deductible, with a beneficiary copay of 20%. The pump must be ordered by the treating physician and obtained from a Medicare-enrolled DME supplier.

CGM Integration and the Case for Pump Therapy

If you are using or requesting a continuous glucose monitor (CGM) alongside an insulin pump, the clinical case for CSII becomes stronger. Sensor-augmented pump therapy with low glucose suspend or hybrid closed-loop features (sometimes called "artificial pancreas" systems) has strong clinical evidence showing:

• Fewer hypoglycemic events
• Better time-in-range
• Improved A1C

When appealing, document whether the denied pump includes integration with a CGM system you already have or have been approved for. The combination strengthens the medical necessity argument.

How to Appeal an Insulin Pump Denial

Step 1: Get the denial letter. Read the specific criteria the insurer says were not met.

Step 2: Contact your endocrinologist's office. Ask the endocrinologist (or your prescribing physician) to specifically address each unmet criterion. This may require:

• A letter of medical necessity tailored to the insurer's exact criteria
• Glucose log data (if the insurer claims insufficient hypoglycemia documentation)
• A1C trend documentation
• Documentation of carb counting training

Step 3: Pull your glucose data. Most glucose meters and CGM devices have downloadable reports. A report showing glycemic variability, hypoglycemic events, or elevated A1C directly addresses the most common denial criteria.

Step 4: Reference clinical guidelines. In your appeal, cite ADA Standards of Medical Care in Diabetes and AACE guidelines supporting CSII therapy for your specific clinical indication.

Step 5: Submit the internal appeal. Make sure to include all documentation and request a response within the plan's required timeline (typically 30–60 days for standard appeals, 72 hours for expedited).

Step 6: Request External Independent Review: Complete Guide" class="auto-link">external review if denied. External reviewers applying clinical standards rather than the insurer's proprietary criteria frequently approve insulin pump appeals that the insurer denied.

If You Cannot Wait for the Appeal

Some people need a pump immediately due to a clinical emergency (severe recurrent hypoglycemia, pregnancy requiring tight control). In this case:

• Request an expedited appeal citing the urgent clinical need
• Ask your physician to document the clinical urgency in writing
• Consider applying for a loaner or trial pump from the manufacturer while the appeal is pending (Medtronic, Omnipod, and Tandem all have patient access programs)

Fight Back With ClaimBack

ClaimBack's free AI tool drafts a professional appeal letter in minutes, tailored to your insurer and denial reason. Don't let a denial be the final word.

Fight your denial at ClaimBack →

Related Reading:

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal